对于患有急性淋巴细胞白血病的儿童的免疫接种建议
Berenice Sánchez-Jara1, Alfonso R Torres-Jiménez2, María G Ortiz-Torres1
1Servicio de Hematología Pediátrica.
Gaceta medica de Mexico
|December 26, 2025
概括
墨西哥的儿童癌症幸存者需要及时接种疫苗. 本综述检查了化学疗法期间和之后急性淋巴细胞白血病患者的安全和有效的疫苗选择.
科学领域:
- 儿科瘤学 儿科瘤学
- 免疫学 免疫学 免疫学
- 公共卫生 公共卫生
背景情况:
- 癌症是墨西哥5至14岁儿童的主要死亡原因,急性白血病是最常见的恶性瘤.
- 接种疫苗对于这些儿童至关重要,但在密集治疗期间往往具有挑战性.
- 了解疫苗类型及其在化疗期间的使用对于提高生存率至关重要.
研究的目的:
- 审查墨西哥为患有急性淋巴细胞白血病 (ALL) 的儿童提供的疫苗.
- 评估有关不同类型疫苗在瘤治疗期间和之后的安全性和有效性的科学证据.
- 为了确定接受化疗的儿科ALL患者的最佳疫苗接种时间.
主要方法:
- 对墨西哥可用的疫苗进行了全面的审查.
- 分析了关于儿童瘤患者疫苗安全性和疗效的科学文献.
- 评估了急性淋巴细胞白血病化疗期间和之后接种疫苗的指导方针.
主要成果:
- 非活体疫苗 (毒素,蛋白质子单元,细菌抗原,重组蛋白) 在治疗ALL的化疗期间不适用.
- 审查确定了特定的疫苗指示和证据,以证明它们在这个患者群体中的使用.
- 在治疗期间和治疗后考虑了疫苗的最佳时间.
结论:
- 在化疗期间,可以安全地给患有急性淋巴细胞白血病的儿童注射非活体疫苗.
- 关于疫苗选择和时间的基于证据的建议对于儿科癌症护理至关重要.
- 本综述为管理墨西哥儿童ALL幸存者的疫苗计划的医疗保健提供者提供了有价值的信息.
关键词:
急性淋巴细胞白血病 (Acute Lymphoblastic Leukemia) 是一种急性淋巴细胞白血病.免疫抑制是一种免疫抑制.免疫抑制是一种免疫抑制.淋巴细胞白血病急性淋巴细胞白血病疫苗 疫苗是一种疫苗.疫苗是一种疫苗.更多相关视频
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
1.7K
10:49Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
18.5K
相关概念视频
01:25Immunodeficiency Diseases
1.9K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
1.9K
01:22Development of Immunocompetence
769
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
769
01:22Bone Marrow Sampling and Transplants
809
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
809
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
191
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
191